Relationship between risk score and clinicopathological characteristics of patients in training set were analyzed in Fig. 4A. It revealed that risk score was lower in breast cancer patients ≤ 60 years, T1 stage, PR positive, HER2 negative, and pre menopause status. The gene discussed is ERBB2; the disease is breast cancer.